Dow Down 0.62% Nasdaq Up 0.35%

Cytokinetics, Incorporated (CYTK)

-NasdaqGS
7.00 Up 0.41(6.22%) Feb 10, 4:00PM EST
Prev Close:6.59
Open:6.62
Bid:6.12 x 200
Ask:12.49 x 500
1y Target Est:19.50
Beta:1.0432
Next Earnings Date:16-Feb-16CYTK Earnings announcement
Day's Range:6.47 - 7.04
52wk Range:5.50 - 13.18
Volume:588,674
Avg Vol (3m):502,773
Market Cap:271.93M
P/E (ttm):N/A
EPS (ttm):-0.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CYTKUp 6.22%271.93M
LGNDDown 1.47%1.76B
BIIBUp 0.88%55.15B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.30
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.04
Quarterly EPS Est (Dec-15) :-0.32
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.46

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytokinetics, Incorporated, a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback